Skip to main content

Microbial diversity

Microbial diversity in coastal Casuarina equisetifolia forest and its potential in counteracting bacterial wilt infections


BACKGROUND


Casuarina wilt is a destructive soil-borne disease caused by Ralstonia solanacearum species complex (RSSC). Recent large-scale outbreaks of Casuarina wilt in the coastal regions of Guangdong Province, China, suggest that the originally resistant Casuarina clones become susceptible to RSSC infection. This study aimed to investigate the microbial diversity of environmental microorganisms and its potential in biocontrol of this devastating disease.

RESULTS


The results unveiled the dominant and common microbial species in Casuarina equisetifolia tree tissues, the rhizosphere soils and seawater in the vicinity of Casuarina equisetifolia forest belt. We also found a range of bacterial species with potent antimicrobial activities against Ralstonia pseudosolanacearum. Both the Casuarina endophyte A1-5, identified as Bacillus velezensis, and a combination biocontrol agent named CEP consisting of three mutually compatible soil isolates belonging to Citrobacter farmeri, Enterobacter aerogenes, and Pseudomonas mosselii, respectively, could effectively control the R. pseudosolanacearum infections on Casuarina and tomato. The active substance of strain A1-5 that inhibits the growth of R. pseudosolanacearum was purified and identified as surfactin C.

CONCLUSION


The findings unveiled the microbial diversity and their specific distributions in the Guangdong coastal Casuarina equisetifolia forest areas, and present useful clues and resources for developing new strategies to prevent and control the Casuarina bacterial wilt. © 2025 Society of Chemical Industry.

bacterial infection, viral infection, fungal infection, parasitic infection, antimicrobial resistance, contagious diseases, infectious disease prevention, sepsis, nosocomial infections, zoonotic diseases, immune response, vaccination, epidemic, pandemic, outbreak control, pathogen, incubation period, transmission routes, asymptomatic carriers, infection control

#InfectionControl, #AntibioticResistance, #PublicHealth, #DiseasePrevention, #ViralInfection, #BacterialInfection, #FungalInfection, #InfectiousDiseases, #PandemicPreparedness, #VaccinesWork, #SepsisAwareness, #HygieneMatters, #ContagiousDiseases, #ZoonoticInfections, #HospitalInfections, #GlobalHealth, #HealthSecurity, #InfectionPrevention, #PathogenAlert, #StopTheSpread

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Post a Comment

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...
Post a Comment
Read more

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...
Post a Comment
Read more